E2/LNG oral (Wellnara, BAY86-5029)

DRUG2 trials

Sponsors

Bayer

Conditions

Osteoporosis, PostmenopausalPostmenopause

Unknown Phase

Effects of Wellnara on Climacteric Symptoms

CompletedNCT00913926

BayerPostmenopause

Start: 2007-09-30End: 2009-05-31Updated: 2015-04-22

Wellnara Post-marketing Surveillance in Japan

CompletedNCT01401114

BayerOsteoporosis, Postmenopausal

Start: 2009-03-31End: 2014-09-30Updated: 2015-09-28